{"id":3565,"count":7,"description":"Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder affecting 5\u201310% of adults, characterised by abdominal pain associated with altered bowel habit. Inflammatory bowel disease (IBD \u2014 ulcerative colitis and Crohn's disease) is a distinct group of immune-mediated chronic inflammatory conditions affecting younger adults disproportionately. The MedsBase IBS Treatment catalogue groups medications for both. Pozn\u00e1mka:<\/strong> the category name historically said \"IBS\" but most products are IBD-specific (mesalamine, sulfasalazine) \u2014 we are reorganising. All products are supplied by WHO-GMP certifikovan\u00fdch v\u00fdrobc\u016f<\/strong>.\n\n5-ASA \/ mesalamin \u2014 pro udr\u017eovac\u00ed l\u00e9\u010dbu ulcer\u00f3zn\u00ed kolitidy a m\u00edrn\u00e9 a\u017e st\u0159edn\u00ed vzplanut\u00ed.<\/strong> Peror\u00e1ln\u00ed mesalamin (5-aminosalicylov\u00e1 kyselina) je l\u00e9kem prvn\u00ed volby pro udr\u017eovac\u00ed l\u00e9\u010dbu ulcer\u00f3zn\u00ed kolitidy a \u00fa\u010dinn\u00fd p\u0159i m\u00edrn\u011b a\u017e st\u0159edn\u011b t\u011b\u017ek\u00fdch vzplanut\u00edch. Jednotliv\u00e9 zna\u010dky se li\u0161\u00ed vzorcem uvol\u0148ov\u00e1n\u00ed (kontrolovan\u00e9 uvol\u0148ov\u00e1n\u00ed pH-dependentn\u00ed, \u010dasov\u011b z\u00e1visl\u00e9, multi-matrix), co\u017e ur\u010duje, kde ve st\u0159ev\u011b se \u00fa\u010dinn\u00e1 l\u00e1tka uvol\u0148uje \u2014 v\u00fdb\u011br zna\u010dky p\u0159izp\u016fsobte rozsahu onemocn\u011bn\u00ed. Skladem jako Mesacol<\/a>, Mesacol OD<\/a> (jednou denn\u011b kontrolovan\u00e9 uvol\u0148ov\u00e1n\u00ed pro dist\u00e1ln\u00ed posti\u017een\u00ed), a Asacol<\/a> (pokud je skladem). Topick\u00fd mesalamin (\u010d\u00edpky, p\u011bna) pro dist\u00e1ln\u00ed proktitidu je uveden v na\u0161\u00ed kategorii Gastro Health jako Pentasa Suppositories.\n\nSulfasalazin \u2013 pro IBD a revmatoidn\u00ed artritidu.<\/strong> Sulfasalazin kombinuje 5-ASA se sulfapyridinem (azo-vazebn\u00fd nosi\u010d, kter\u00fd uvol\u0148uje 5-ASA v tlust\u00e9m st\u0159ev\u011b). Standardn\u00ed d\u00e1vka pro ulcer\u00f3zn\u00ed kolitidu je 2\u20134 g denn\u011b v rozd\u011blen\u00fdch d\u00e1vk\u00e1ch. Skladem jako Sazo<\/a> a Salazar<\/a>. Mesalamin s \u010dist\u0161\u00edm profilem ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f je obvykle preferov\u00e1n pro IBD; sulfasalazin je st\u00e1le u\u017eite\u010dn\u00fd tam, kde se vyskytuje IBD-asociovan\u00e1 artropatie nebo revmatoidn\u00ed artritida (sulfapyridinov\u00e1 slo\u017eka m\u00e1 DMARD aktivitu).\n\nMebeverin \u2013 antispasmodikum pro IBS.<\/strong> Mebeverin (hladkosvalov\u00e9 antispasmodikum) je prvn\u00ed volbou pro IBS s p\u0159evl\u00e1daj\u00edc\u00edmi k\u0159e\u010demi a spasmy \u2013 u\u017e\u00edv\u00e1 se 20 minut p\u0159ed j\u00eddlem. Skladem jako Colospa<\/a>. Profil ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f je p\u0159\u00edzniv\u00fd; skromn\u00e1 d\u016fkazov\u00e1 z\u00e1kladna ze star\u0161\u00edch studi\u00ed.\n\nRifaximin \u2013 pro IBS-D a SIBO.<\/strong> Rifaximin je neabsorbovan\u00e9 lumin\u00e1ln\u00ed antibiotikum s schv\u00e1len\u00edm FDA pro IBS-D a \u0161ir\u0161\u00edm pou\u017eit\u00edm p\u0159i bakteri\u00e1ln\u00edm p\u0159er\u016fst\u00e1n\u00ed tenk\u00e9ho st\u0159eva (SIBO) a jatern\u00ed encefalopatii. L\u00e9\u010dba je 550 mg t\u0159ikr\u00e1t denn\u011b po dobu 2 t\u00fddn\u016f; zlep\u0161en\u00ed p\u0159\u00edznak\u016f p\u0159etrv\u00e1v\u00e1 m\u011bs\u00edce u mnoha respondent\u016f. Skladem jako Rifagut<\/a>.\n\nWhat's NOT here.<\/strong> Biologic therapy (infliximab, adalimumab, vedolizumab, ustekinumab, tofacitinib) for moderate-severe IBD requires specialist initiation and monitoring \u2014 not stocked. Corticosteroids for IBD flares: oral budesonide for ileal Crohn's and right-sided UC is in our Gastro Health category as Budez CR; systemic prednisolone is in Pain Relief Medication.\n\nJak vybrat.<\/strong> Mild-moderate ulcerative colitis \u2192 oral mesalamine first-line + topical 5-ASA for distal disease + check adherence. Mild-moderate Crohn's \u2192 mesalamine has limited evidence (works in colonic disease only); budesonide for ileal disease. IBS-C (constipation-predominant) \u2192 osmotic \/ stimulant laxatives (see Constipation Medicine category) \u00b1 linaclotide \/ lubiprostone where available. IBS-D (diarrhoea-predominant) \u2192 rifaximin 2-week course; consider eluxadoline. IBS-M (mixed) \u2192 antispasmodic (mebeverine) + lifestyle \/ FODMAP diet trial. Refractory or alarm features (weight loss, blood, anaemia, age > 50, family history of IBD or CRC) \u2192 urgent gastroenterology referral.\n\nD\u016fle\u017eit\u00e9.<\/strong> IBD flares require tighter management than IBS (significant disease can be silent on standard therapy, and untreated flares progress to complications including stricture, fistula, dysplasia, and need for colectomy). Annual review with calprotectin \/ endoscopy as appropriate. Pregnancy: most 5-ASAs and sulfasalazine are continued through pregnancy; folic acid supplementation needed for sulfasalazine. Methotrexate and many biologics carry pregnancy restrictions. New diarrhoea in IBD or worsening symptoms can be C. difficile \u2014 test before assuming flare.\n\nAll MedsBase IBS Treatment products ship from WHO-GMP certifikovan\u00fdch v\u00fdrobc\u016f<\/strong> s diskr\u00e9tn\u00edm balen\u00edm a jsou kryty na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>.\n\n2026 buyer's guide:<\/strong> Prohl\u00e9dn\u011bte si n\u00e1\u0161 v\u00fdb\u011br Nejlep\u0161\u00ed l\u00e9\u010dba IBS & IBD 2026<\/a> pro se\u0159azen\u00e9 tipy, srovn\u00e1vac\u00ed tabulku, d\u00e1vkov\u00e1n\u00ed a zkratku k rozhodnut\u00ed.","link":"https:\/\/medsbase.com\/cs\/irritable-bowel-syndrome-ibs-treatment\/","name":"L\u00e9\u010dba syndromu dr\u00e1\u017ediv\u00e9ho tra\u010dn\u00edku (IBS)","slug":"irritable-bowel-syndrome-ibs-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product?product_cat=3565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}